Athersys to Present at 12th Annual Needham Healthcare Conference

Athersys to Present at 12th Annual Needham Healthcare Conference

CLEVELAND, April 25, 2013 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX)
announced today that Gil Van Bokkelen, Ph.D., Chairman and Chief Executive
Officer, will present at the 12^th Annual Needham Healthcare Conference to be
held at The Westin New York Grand Central from April 30 - May 1, 2013 in New
York City.

Details of Athersys' participation are as follows:

Event:    12^th Annual Needham Healthcare Conference
Date:     Wednesday, May 1, 2013
Time:    9:20 a.m. Eastern Daylight Time
Location: The Westin New York Grand Central

The presentation will also be available via a live audio webcast at the
following link:

Following the presentation, a replay will be available through the Athersys
website at under the "Investors" section and will remain
available for two weeks after the actual presentation date.

About Athersys

Athersys is a clinical stage biotechnology company engaged in the discovery
and development of therapeutic product candidates designed to extend and
enhance the quality of human life. The Company is developing its MultiStem^®
cell therapy product, a patented, adult-derived "off-the-shelf" stem cell
product platform for disease indications in the cardiovascular, neurological,
inflammatory and immune disease areas. The Company currently has several
clinical stage programs involving MultiStem, including for treating
inflammatory bowel disease, ischemic stroke, damage caused by myocardial
infarction, and for the prevention of graft versus host disease. Athersys has
also developed a diverse portfolio that includes other technologies and
product development opportunities, and has forged strategic partnerships and
collaborations with leading pharmaceutical and biotechnology companies, as
well as world-renowned research institutions in the United States and Europe
to further develop its platform and products. More information is available at

CONTACT: William (B.J.) Lehmann, J.D.
         President and Chief Operating Officer
         Tel: (216) 431-9900
         Investor Relations:
         Lisa M. Wilson
         In-Site Communications
         Tel: (917) 543-9932

company logo
Press spacebar to pause and continue. Press esc to stop.